Cirius Therapeutics, Inc. — Form D

Cirius Therapeutics, Inc. of GRAND RAPIDS, MI, a company, filed a Form D exempt-offering notice with the SEC on 2024-08-20. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Michael A JandernoaDirectorGrand Rapids, MI
Robert A BeardsleyExecutive OfficerGrand Rapids, MI
Robert A ZerbeDirectorGrand Rapids, MI
David A Van AndelDirectorGrand Rapids, MI
Jerry A CallahanExecutive OfficerGrand Rapids, MI
David Van AndelDirectorGrand Rapids, MI
Michael JandernoaDirectorKalamazoo, MI
Mark OlesnavageExecutive OfficerKalamazoo, MI
Robert BeardsleyExecutive OfficerSt. Louis, MO
Jerry CallahanExecutive OfficerGrand Rapids, MI
Robert ZerbeDirectorGrand Rapids, MI
Elaine SunDirectorSOUTH SAN FRANCISCO, CA
Daniel EstesDirectorCarmel, IN
Nilesh KumarDirectorWatertown, MA
Daniel Estes, Ph.D.DirectorMenlo Park, CA
Baltera BobDirectorSan Diego, CA
Baltera BobExecutive OfficerSan Diego, CA
Nilesh Kumar, Ph.D.DirectorSan Diego, CA
Robert Zerbe, M.D.DirectorSan Diego, CA
Dennis Fenton, Ph.D.DirectorSan Diego, CA
Brian FarmerExecutive OfficerSan Diego, CA
Robert BalteraDirectorKalamazoo, MI
Robert BalteraExecutive OfficerKalamazoo, MI
Howard DittrichExecutive OfficerKalamazoo, MI

Other filings by this issuer (5)

FiledFormOfferingSold
2025-10-08D$1.2M$800K
2024-10-15D$1.6M$1.0M
2019-05-14D$7.5M$7.5M
2018-08-30D$9.0M$9.0M
2017-04-10D$40.5M$30.0M

More